Page last updated: 2024-08-24

lamivudine and Hematologic Diseases

lamivudine has been researched along with Hematologic Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, FW; Coyle, L; Jones, BE; Pattullo, V1
Aloe-Spiriti, MA; Angeletti, S; Cipriani, P; Cox, MC; Delle Fave, G; Gallina, S; Leone, F; Marignani, M; Monarca, B; Veggia, B1
Balducci, M; Clementi, M; Manzin, A; Petrelli, E; Pieretti, C; Rocchi, MB1

Other Studies

3 other study(ies) available for lamivudine and Hematologic Diseases

ArticleYear
Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease.
    Liver international : official journal of the International Association for the Study of the Liver, 2013, Volume: 33, Issue:8

    Topics: Aged; Antiviral Agents; Biomarkers; Chi-Square Distribution; DNA, Viral; Drug Administration Schedule; Drug Resistance, Viral; Female; Guanine; Hematologic Diseases; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Patient Selection; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Virus Activation

2013
Is management with lamivudine always the appropriate choice for HBV patients with onco-hematologic diseases?
    Annals of hematology, 2009, Volume: 88, Issue:3

    Topics: Choice Behavior; Disease Management; Follow-Up Studies; Hematologic Diseases; Hepatitis B, Chronic; Humans; Lamivudine

2009
Lamivudine treatment failure in preventing fatal outcome of de novo severe acute hepatitis B in patients with haematological diseases.
    Journal of hepatology, 2001, Volume: 35, Issue:6

    Topics: Acute Disease; Adult; Aged; Child; Cross Infection; Disease Outbreaks; Fatal Outcome; Female; Hematologic Diseases; Hepatitis B; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Treatment Failure

2001